Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
Authors:
Open Access
- 28 June 2023
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 13 (1) , 1-19
Abstract
Background: Artemisia argyi (A. argyi), also called Chinese mugwort, has been widely used to control pandemic diseases for thousands of years since ancient China due to its anti-microbial infection, anti-allergy, and anti-inflammation activities. Therefore, the potential of A. argyi and its constituents in reducing the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was investigated in this study. Results: Among the phytochemicals in A. argyi, eriodictyol and umbelliferone were identified to target transmembrane serine protease 2 (TMPRSS2) and angiotensin-converting enzyme 2 (ACE2) proteins, the essential factors for the cellular entry of SARS-CoV-2, in both FRET-based enzymatic assays and molecular docking analyses. These two ingredients of A. argyi suppressed the infection of ACE2-expressed HEK-293 T cells with lentiviral-based pseudo-particles (Vpp) expressing wild-type and variants of SARS-CoV-2 spike (S) protein (SARS-CoV-2 S-Vpp) via interrupting the interaction between S protein and cellular receptor ACE2 and reducing the expressions of ACE2 and TMPRSS2. Oral administration with umbelliferone efficiently prevented the SARS-CoV-2 S-Vpp-induced inflammation in the lung tissues of BALB/c mice. Conclusions: Eriodictyol and umbelliferone, the phytochemicals of Artemisia argyi, potentially suppress the cellular entry of SARS-CoV-2 by preventing the protein binding activity of the S protein to ACE2.Keywords
All Related Versions
Funding Information
- Ministry of Science and Technology (MOST 111-2320-B-039-027-MY3, MOST 110-2320-B-039-056-MY, MOST 111-2320-B-039-016-MY3, MOST 111-2811-B-039-028, MOST 111-2320-B-039 -036)
- China Medical University Hospital (CMUH-DMR-111-025, CMUH-DMR-110-026, CMUH-DMR-110-028, CMUHCH-DMR-110-006)
This publication has 56 references indexed in Scilit:
- Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredientsPhytomedicine, 2019
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factorsNature Communications, 2019
- Phytochemical components and biological activities of Artemisia argyiJournal of Functional Foods, 2019
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compoundsAntiviral Research, 2015
- Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genesAnti-Cancer Drugs, 2012
- Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discoveryVirus Research, 2008
- 13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cellsBiochemical Pharmacology, 2007
- PPARγ as a new therapeutic target in inflammatory bowel diseasesGut, 2006
- Metabolism of oxidized linoleic acid: characterization of 13-hydroxyoctadecadienoic acid dehydrogenase activity from rat colonic tissueBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Oxidative metabolism of linoleic acid by human leukocytesBiochemical and Biophysical Research Communications, 1989